Concepedia

Author

Jean‐Michel Rivet

AVL (France)

Also Known As

J M RIVET, J M Rivet, J Rivet, J. -M. Rivet, J. ‐M. Rivet, J.-M Rivet, J.-M. Rivet, J.M. Rivet, J.‐M. Rivet, Jean-Michel Rivet

102

Publications

5.9K

Citations

43

H-Index

67

Concepts

All Affiliations

AVL (France)Servier (France)InsermUniversité de Bordeaux
JR

About

Jean‐Michel Rivet is an author at AVL (France) specializing in neuroscience, neuropharmacology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

41

2.6K

2

Social Sciences

25

34

2.3K

3

Health Sciences

2

2

71

4

Behavioral Sciences

1

1

120

5

Biochemistry

1

1

52

Jean‐Michel Rivet

×

75

Publications

5.8K

Citations

42

H-Index

YearCitations

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

Mark J. Millan, Alain P. Gobert, F. Lejeune,

Journal of Pharmacology and Experimental Therapeutics

2003

509

Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

Alain P. Gobert, Jean‐Michel Rivet, F. Lejeune,

Synapse

2000

335

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release

Alain P. Gobert, Jean‐Michel Rivet, Valérie Audinot,

Neuroscience

1998

203

Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

Mark J. Millan, Adrian Newman‐Tancredi, Val�rie Audinot,

Synapse

2000

191

Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex

Pascal Fossat, Fabrice Turpin, Silvia Sacchi,

Cerebral Cortex

2011

184

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α<sub>2</sub>‐adrenergic and serotonin<sub>2C</sub> receptors: a comparison with citalopram

Mark J. Millan, Alain P. Gobert, Jean‐Michel Rivet,

European Journal of Neuroscience

2000

167

5‐HT <sub>6</sub> receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

Julie Meffre, Séverine Chaumont‐Dubel, Clotilde Mannoury la Cour,

EMBO Molecular Medicine

2012

162

S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine

M J Millan, Alain P. Gobert, F. Lejeune,

Journal of Pharmacology and Experimental Therapeutics

2001

143

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5‐HT<sub>2A</sub> sites for PCP‐induced locomotion in the rat

Mark J. Millan, Mauricette Brocco, Alain P. Gobert,

European Journal of Neuroscience

1999

138

Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline.

Mark J. Millan, K Bervoets, Jean‐Michel Rivet,

Journal of Pharmacology and Experimental Therapeutics

1994

136

Page 1